Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | LTB4R | Q15722 | 6/20 | 0.38 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 3/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | FABP4 | P15090 | 1/20 | 0.36 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.36 |
| ▸ | ACSL6 | Q9UKU0 | 1/20 | 0.36 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | FABP1 | P07148 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16521954 | 0.84 | CNR1 (0.39) | TSHRCNR2ALDH1A1 | |
| SCHEMBL4782366 | 0.84 | S1PR3 (0.49) | S1PR3CNR2ALDH1A1 | |
| SCHEMBL31187734 | 0.84 | S1PR3 (0.49) | S1PR3CNR2ALDH1A1 | |
| SCHEMBL4783019 | 0.84 | S1PR3 (0.49) | S1PR3CNR2ALDH1A1 | |
| SCHEMBL4778946 | 0.84 | S1PR3 (0.49) | S1PR3CNR2ALDH1A1 | |
| SCHEMBL4783640 | 0.84 | S1PR3 (0.49) | S1PR3CNR2ALDH1A1 | |
| SCHEMBL31187743 | 0.84 | S1PR3 (0.49) | S1PR3CNR2ALDH1A1 | |
| SCHEMBL31187737 | 0.84 | S1PR3 (0.49) | S1PR3CNR2ALDH1A1 | |
| SCHEMBL592602 | 0.83 | S1PR3 (0.51) | S1PR3CNR2ALDH1A1 | |
| SCHEMBL10598677 | 0.83 | S1PR3 (0.48) | S1PR3CNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8658434-B2 | Fluorescent pyrene compounds | BIOTIUM, INC. (US) | 2014-02-25 | — | — | US | disclosed |
| US-20110097735-A1 | FLUORESCENT PYRENE COMPOUNDS | BIOTIUM, INC. (US) | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110097735-A1 | FLUORESCENT PYRENE COMPOUNDS | PAH, CYP1A1, PYCR1 | ALB 3871/4885TSHR 4193/4885S1PR3 2540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.